Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01709825 · ClinicalTrials.gov registry record · NA

The Effect of Probiotics (L. Helveticus, B. Longum, and B. Bifidum) on Immune Function and Digestive Health

A NA study of Healthy, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
583
Enrollment target
1
Study location

NCT01709825 is a NA study of Healthy that has completed, run by University of Florida. The registered enrollment target is 583 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01709825, a NA study of Healthy, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
583 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if daily consumption of a probiotic in the period before, during and after academic exams will help maintain digestive and immune health and quality of life of undergraduate students.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Probiotic- Bifidobacterium Bifidum
  • DIETARY_SUPPLEMENT Sugar Pill
  • DIETARY_SUPPLEMENT Probiotic- Lactobacillus helveticus
  • DIETARY_SUPPLEMENT Probiotic- Bifidobacterium longum ss. Infantis R0033

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 583 participants
Start Date 2012-09
Est. Completion 2013-01
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT01709825

The ClinicalTrials.gov registry entry for NCT01709825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 583 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (10% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Probiotic- Bifidobacterium Bifidum is the first listed.

NCT01709825 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01709825 about?

NCT01709825 is a clinical study titled "The Effect of Probiotics (L. Helveticus, B. Longum, and B. Bifidum) on Immune Function and Digestive Health". The purpose of this study is to determine if daily consumption of a probiotic in the period before, during and after academic exams will help maintain digestive and immune health and quality of life of undergraduate students.

What is the current status of trial NCT01709825?

This trial is currently completed. It is a NA study. The enrollment target is 583 participants. The study started on 2012-09. Estimated completion is 2013-01.

What conditions does trial NCT01709825 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01709825?

The interventions under investigation include: Probiotic- Bifidobacterium Bifidum (DIETARY_SUPPLEMENT), Sugar Pill (DIETARY_SUPPLEMENT), Probiotic- Lactobacillus helveticus (DIETARY_SUPPLEMENT), Probiotic- Bifidobacterium longum ss. Infantis R0033 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01709825?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01709825 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.